|
Marshall, D J; Palasis, M; Lepore, J J et al. (2000) Biocompatibility of cardiovascular gene delivery catheters with adenovirus vectors: an important determinant of the efficiency of cardiovascular gene transfer. Mol Ther 1:423-9
|
|
Leiden, J M (2000) Human gene therapy: the good, the bad, and the ugly. Circ Res 86:923-5
|
|
Svensson, E C; Marshall, D J; Woodard, K et al. (1999) Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 99:201-5
|
|
Marshall, D J; Leiden, J M (1998) Recent advances in skeletal-muscle-based gene therapy. Curr Opin Genet Dev 8:360-5
|
|
Svensson, E C; Black, H B; Dugger, D L et al. (1997) Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 8:1797-806
|
|
Kim, S; Lin, H; Barr, E et al. (1997) Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest 100:1006-14
|
|
La Motte, R N; Rubin, M A; Barr, E et al. (1996) Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory molecule. Cancer Immunol Immunother 42:161-9
|
|
Tripathy, S K; Black, H B; Goldwasser, E et al. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545-50
|
|
Tripathy, S K; Svensson, E C; Black, H B et al. (1996) Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc Natl Acad Sci U S A 93:10876-80
|
